Mesenchymal stem cell‐derived exosomes protect muscle loss by mir‐145‐5p activity targeting activin a receptors

Kyung Ah Cho, Da Won Choi, Yu Hee Kim, Jungwoo Kim, Kyung Ha Ryu, So Youn Woo

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Skeletal muscle mass is decreased under a wide range of pathologic conditions. In partic-ular, chemotherapy is well known for inducing muscle loss and atrophy. Previous studies using tonsil‐derived mesenchymal stem cells (T‐MSCs) or a T‐MSC‐conditioned medium showed effective recovery of total body weight in the chemotherapy‐preconditioned bone marrow transplantation mouse model. This study investigated whether extracellular vesicles of T‐MSCs, such as exosomes, are a key player in the recovery of body weight and skeletal muscle mass in chemotherapy‐treated mice. T‐MSC exosomes transplantation significantly decreased loss of total body weight and muscle mass in the busulfan‐cyclophosphamide conditioning regimen in BALB/c recipient mice containing elevated serum activin A. Additionally, T‐MSC exosomes rescued impaired C2C12 cell differentiation in the presence of activin A in vitro. We found that T‐MSC exosomes possess abundant miR‐ 145‐5p, which targets activin A receptors, ACVR2A, and ACVR1B. Indeed, T‐MSC exosomes rescue muscle atrophy both in vivo and in vitro via miR‐145‐5p dependent manner. These results suggest that T‐MSC exosomes have therapeutic potential to maintain or improve skeletal muscle mass in various activin A elevated pathologic conditions.

Original languageEnglish
Article number2169
Issue number8
StatePublished - Aug 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Li-censee MDPI, Basel, Switzerland.


  • Activin A
  • Exosomes
  • Mesenchymal stem cell
  • Skeletal muscle


Dive into the research topics of 'Mesenchymal stem cell‐derived exosomes protect muscle loss by mir‐145‐5p activity targeting activin a receptors'. Together they form a unique fingerprint.

Cite this